Prof. Michael E. Boulton, PhD, and his research team joined the faculty at the University of Alabama Birmingham in 2017 to expand the ongoing basic and translational research within the Department of Ophthalmology and Visual Sciences using a range of cell, molecular, and animal models to better understand retinal pathophysiology and to improve treatment of retinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy. Dr Boulton’s research group has over 35 years of experience in vision research and has published over 240 peer-reviewed articles. His research is focused on three broad areas: 1) RPE responses to oxidative stress and the potential for RPE regeneration/cellular therapy, 2) the importance of circadian rhythmicity in retinal repair and regeneration, and 3) identifying the factors that regulate retinal and choroidal neovascularization. Current research areas include: Investigating the role of BACE1 in retinal pathophysiology; Dissecting the interplay between mitochondria, autophagy and lysosomal degradation in retinal degeneration; Using programmed bone marrow-derived cells as a systemic therapy for retinal degeneration.
Prof. Michael E. Boulton, PhD, and his research team joined the faculty at the University of Alabama Birmingham in 2017 to expand the ongoing basic and translational research within the Department of Ophthalmology and Visual Sciences using a range of cell, molecular, and animal models to better understand retinal pathophysiology and to improve treatment of retinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy. Dr Boulton’s research group has over 35 years of experience in vision research and has published over 240 peer-reviewed articles. His research is focused on three broad areas: 1) RPE responses to oxidative stress and the potential for RPE regeneration/cellular therapy, 2) the importance of circadian rhythmicity in retinal repair and regeneration, and 3) identifying the factors that regulate retinal and choroidal neovascularization. Current research areas include: Investigating the role of BACE1 in retinal pathophysiology; Dissecting the interplay between mitochondria, autophagy and lysosomal degradation in retinal degeneration; Using programmed bone marrow-derived cells as a systemic therapy for retinal degeneration.